§ Same category · GLP-1 / metabolic peptides
Retatrutide vs Survodutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Retatrutide
0
vendors tracked
Survodutide
0
vendors tracked
Retatrutide
Triple GCG/GIP/GLP-1 agonist
No current listings at 10mg.
Survodutide
Glucagon/GLP-1 dual agonist
No current listings at 10mg.
About Retatrutide
An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.